The present invention is directed to compounds of the formula I: 1
(wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7,
R.sup.8, R.sup.9, R.sup.10, X, n and the dashed line are defined herein)
which are useful as modulators of chemokine receptor activity. In
particular, these compounds are useful as modulators of the chemokine
receptor CCR-2. The present invention is also directed to intermediates
useful in the preparation of formula I compounds.
